Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Imaging Tau in Alzheimer's Disease and Normal Aging (NCT03373604)Patrick Lao2017-12-11
Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC (NCT03366376)Samsung Medical Center2017-12-11
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM (NCT03596086)David Baskin MD2017-12-11
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor (NCT03399253)Sun Yat-sen University2017-12-10
Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus (NCT03540212)Ain Shams University2017-12-10
Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis (NCT03368339)Realm Therapeutics, Inc.2017-12-10
Pembrolizumab in Untreated Extensive SCLC (NCT02580994)European Organisation for Research and Treatment of Cancer - EORTC2017-12-08
Study of BCMA CAR-T in Multiple Myeloma (NCT03322735)Henan Cancer Hospital2017-12-08
Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects (NCT03264157)Bio Products Laboratory2017-12-08
A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma (NCT03301636)NewLink Genetics Corporation2017-12-08
A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients. (NCT03231878)Minoryx Therapeutics, S.L.2017-12-08
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation (NCT03159702)Medical College of Wisconsin2017-12-08
Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma (NCT03046953)University of Birmingham2017-12-08
The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology (NCT03294941)HepQuant, LLC2017-12-08
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) (NCT03282474)Hannover Medical School2017-12-07
The Effect of Cannabis on Dementia Related Agitation and Aggression (NCT03328676)TO Pharmaceuticals2017-12-07
Locally Advanced NSCLC Hyperfractionated RT (NCT03128008)Duke University2017-12-07
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption (NCT03270085)Mayo Clinic2017-12-07
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer (NCT03206073)National Cancer Institute (NCI)2017-12-07
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma (NCT02974621)National Cancer Institute (NCI)2017-12-07
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months (NCT03351244)Boehringer Ingelheim2017-12-07
A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health (NCT03339713)Janssen Vaccines & Prevention B.V.2017-12-07
A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency (NCT03378531)Aeglea Biotherapeutics2017-12-07
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma (NCT03161756)Melanoma and Skin Cancer Trials Limited2017-12-07
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer (NCT03211416)Roswell Park Cancer Institute2017-12-07
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders (NCT03371888)Medical University of Silesia2017-12-07
Pulmonary Hypertension and Anastrozole Trial (NCT03229499)University of Pennsylvania2017-12-07
Pembrolizumab in Neoplasms or Lymphomas (NCT03316573)Dana-Farber Cancer Institute2017-12-07
The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota (NCT05166746)Peter Humaidan2017-12-07
A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity (NCT03320941)Novartis Pharmaceuticals2017-12-07
Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients (NCT03310645)Bayer2017-12-07
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486)Roswell Park Cancer Institute2017-12-07
High Resolution PET-MRI Before Prostate Cancer HIFU (NCT03263780)Timothy J. Daskivich2017-12-07
Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy (NCT03352934)Johannes Gutenberg University Mainz2017-12-07
Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2) (NCT03340493)Neuroscience Trials Australia2017-12-06
Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations (NCT03352427)University of Michigan Rogel Cancer Center2017-12-06
Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA (NCT03378076)Pacira Pharmaceuticals, Inc2017-12-06
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers (NCT03363776)Bristol-Myers Squibb2017-12-06
Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy (NCT03355560)Trisha Wise-Draper2017-12-06
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects (NCT03382977)VBI Vaccines Inc.2017-12-06
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors (NCT03369223)Bristol-Myers Squibb2017-12-06
Clinical Evaluation of Etafilcon A With Ketotifen (NCT03388138)Johnson & Johnson Vision Care, Inc.2017-12-06
Effect of Memantine on Radiotherapy-related Cognitive Impairment (NCT03342443)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2017-12-06
Microdystrophin Gene Transfer Study in Adolescents and Children With DMD (NCT03368742)Solid Biosciences Inc.2017-12-06
A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy (NCT03499834)Ivy Life Sciences, Co., Ltd2017-12-05
A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas (NCT03277729)Fred Hutchinson Cancer Center2017-12-05
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679)Cellestia Biotech AG2017-12-05
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients (NCT03366272)Universität des Saarlandes2017-12-05
TATE Versus TACE in Intermediate Stage HCC (NCT03145558)Teclison Ltd.2017-12-05
A Factor IX Gene Therapy Study (FIX-GT) (NCT03369444)University College, London2017-12-05
Neurocognitive Decline in Patients With Brain Metastases (NCT03508752)University of Texas Southwestern Medical Center2017-12-05
The Effect of Arginine on Classic Galactosemia (NCT03580122)Academisch Ziekenhuis Maastricht2017-12-05
RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial (NCT04368650)SVS Institute of Dental Sciences2017-12-05
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536)University of Arizona2017-12-05
Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD) (NCT03242928)Novartis Pharmaceuticals2017-12-04
Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound (NCT03245255)Thomas Jefferson University2017-12-04
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure (NCT03292653)Lexicon Pharmaceuticals2017-12-04
A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis (NCT04274257)Tokyo University2017-12-04
Dexamethasone in Controlling Dyspnea in Patients With Cancer (NCT03367156)M.D. Anderson Cancer Center2017-12-04
iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab (NCT03350126)GERCOR - Multidisciplinary Oncology Cooperative Group2017-12-04
A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS) (NCT02829827)UCB Biopharma S.P.R.L.2017-12-04
PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2 (NCT03271281)Rigshospitalet, Denmark2017-12-04
Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) (NCT02483429)Johns Hopkins University2017-12-04
Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis (NCT03351777)Realm Therapeutics, Inc.2017-12-04
Discovery of Sirolimus Sensitive Biomarkers in Blood (NCT03304678)National Heart, Lung, and Blood Institute (NHLBI)2017-12-04
Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma (NCT03190213)University of Utah2017-12-04
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen (NCT03373227)Baylor Research Institute2017-12-04
Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736) (NCT03446547)Vastra Gotaland Region2017-12-04
The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting (NCT03626441)The University of The West Indies2017-12-02
Endometrial Receptivity in Patients With Recurrent Implantation Failure as a Preparatory Step for PET (NCT03361839)Cairo University2017-12-01
PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma (NCT03120000)PIQUR Therapeutics AG2017-12-01
Efficacy and Safety of Rapamycin to Complex Vascular Anomalies in Pediatric Patients (NCT04598204)Zhujiang Hospital2017-12-01
Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection (NCT03352349)Shanghai Zhongshan Hospital2017-12-01
Sharp Versus Blunt Uterine Incision Expansion (NCT03377894)Kasr El Aini Hospital2017-12-01
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer (NCT02972060)European Organisation for Research and Treatment of Cancer - EORTC2017-12-01
Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells(hAECs) (NCT03031509)Shanghai East Hospital2017-12-01
Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer (NCT03391843)RenJi Hospital2017-12-01
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients (NCT03336983)Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2017-12-01
AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3] (NCT03366675)Samsung Medical Center2017-12-01
DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy (NCT03369990)Daewoong Pharmaceutical Co. LTD.2017-12-01
Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment (NCT03389126)Seoul National University Hospital2017-12-01
A Study Examining the Medication Apremilast as Treatment for Chronic Itch (NCT03239106)Washington University School of Medicine2017-12-01
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer (NCT03310632)Golden Biotechnology Corporation2017-12-01
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome (NCT03383380)Children's Hospital of Fudan University2017-12-01
Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ,III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma: A Randomized, Controlled Clinical Study (NCT03368131)Hebei Medical University2017-12-01
QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL (NCT03169790)ImmunityBio, Inc.2017-12-01
Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma (NCT03393858)Capital Medical University2017-12-01
Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant (NCT03330795)National Institute of Allergy and Infectious Diseases (NIAID)2017-12-01
Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease (NCT03300531)Second Affiliated Hospital, Zhejiang University, School of Medicine2017-12-01
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind (NCT03024944)Columbia University2017-12-01
Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex (NCT03389308)Castle Creek Pharmaceuticals, LLC2017-12-01
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy (NCT03169764)ImmunityBio, Inc.2017-12-01
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy (NCT03197571)ImmunityBio, Inc.2017-12-01
Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM (NCT03291249)Tiziana Life Sciences LTD2017-12-01
Endosleeve in Adolescents (NCT03778697)King Saud University2017-12-01
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy (NCT03167164)ImmunityBio, Inc.2017-12-01
Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population (NCT03035578)The Hospital for Sick Children2017-12-01
Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination (NCT03490097)Ain Shams University2017-12-01
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis (NCT02988401)Johns Hopkins University2017-12-01
Mild Encephalopathy in the Newborn Treated With Darbepoetin (NCT03071861)University of New Mexico2017-12-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.